AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zulip-G 1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Arlak Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Zulip-G 1 Tablet ER

Glimepiride-Metformin extended-release tablets are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle modifications are integral to diabetes management. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to recognize its symptoms—sweating, dizziness, headache, and tremors—and how to treat it. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease prior to commencing treatment; it may be unsuitable. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Zulip-G 1 Tablet ER

No text provided to rephrase.

Uses of Zulip-G 1 Tablet ER

Managing type 2 diabetes

Major Benefits of Zulip-G 1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. Zulip-G 1 Extended-Release Tablet should be administered with a meal.

Common Side effects of Zulip-G 1 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zulip-G 1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the extended-release Zulip-G tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Zulip-G 1 Tablet ER works:

Zulip-G 1 ER tablet combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Zulip-G 1 Tablet ER is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Zulip-G tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Zulip-G tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Zulip-G 1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Zulip-G 1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Zulip-G 1 Tablet ER to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced Zulip-G 1 Tablet ER dose; the medication is contraindicated in those with severe liver disease.

What if you forget to take Zulip-G 1 Tablet ER :

Should you forget to take a Zulip-G 1 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zulip-G 1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zulip-G 1 Tablet ER

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Zulip-G 1 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Zulip-G 1 Tablet ER and seek immediate medical attention.
Zulip-G 1 Tablet ER combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Zulip-G 1 Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Zulip-G 1 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Zulip-G 1 Tablet ER can indeed lower blood sugar (cause hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zulip-G 1 Tablet ER and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Zulip-G 1 Tablet ER
34
MRP 39
12% off